Imaging and Functional Readout Audit
One assay or pipeline scored end to end, from fluorophore panel to statistics, with a prioritized fix list you can act on in a week.
Services
Every engagement is a written proposal with a named deliverable, a date and a fixed fee. Imaging and cell-based work comes first; the therapeutics offers are grouped by the decision you need to make.
Imaging and cell-based science
For anyone who generates image or cell data: drug developers, CROs, imaging and instrument vendors, academic cores and tool companies. This is my core work.
Imaging Pipeline and Analysis Build
I design and hand over a rerunnable segmentation, feature-extraction and multivariate analysis pipeline for one assay, with the methods section already written.
Assay and Platform Advisory
Assay validation design, application notes, and the scientific credibility your customers ask you for — written by someone who has bought your product from the sponsor side.
Therapeutics programs
Discovery biology for therapeutics in any modality — antibody, siRNA and ASO, small molecule.
What to build
Assay Cascade Design Sprint
A written cascade from biochemical to translational, with go/no-go criteria at every tier and a build-versus-outsource call per assay.
iPSC Disease Model Build Advisory
The lineage and source decision, the culture format, the readouts, and the QC gates that separate disease from differentiation noise.
PD Biomarker and Target-Engagement Plan
A biomarker hypothesis map from proximal target engagement to pathway PD to disease biomarker, with the assays, the matrices and the validation plan behind it.
Whether the data holds
Scientific Diligence Memo
A bench-level read of a data package — what it does and does not support, where replication risk sits, and the management questions whose answers would change the conclusion.
Who runs it and how
CRO Selection and Study Oversight
I write the RFP, score the vendors, and then sit on your side of the weekly call until the data arrives clean.
Fractional Lead Biologist
Standing ownership of in vitro strategy — team meetings, CRO management, data review, and the science on the board slide.
Book an intro call Four quick questions and your contact details, then pick a time. A first conversation about your data, no pitch.